Results 141 to 150 of about 131,091 (318)
Dynamic chromatin accessibility modeled by Markov process of randomly-moving molecules in the 3D genome. [PDF]
Wang Y, Fan C, Zheng Y, Li C.
europepmc +1 more source
Efficacy, safety and cost‐effectiveness of CAR‐T therapy
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher +7 more
wiley +1 more source
The research on the strong Markov property
Let $X(t, omega) = {x_t(omega): t geq 0} be a Markov process defined on a probability space $(Omega,mathcal{F}, P)$ and valued in a measurable space (E; mathcal{E} ).
Huang Yonghui, Tang Rong
doaj
3D Markov Process for Traffic Flow Prediction in Real-Time. [PDF]
Ko E, Ahn J, Kim EY.
europepmc +1 more source
Hypotheses testing and posterior concentration rates for semi-Markov processes [PDF]
Vlad Ștefan Barbu +3 more
openalex +1 more source
Disentangled Sticky Hierarchical Dirichlet Process Hidden Markov Model [PDF]
Ding Zhou, Yuanjun Gao, Liam Paninski
openalex +1 more source
Carbamazepine is licensed in the United Kingdom for the treatment of epilepsy, bipolar disorder and trigeminal neuralgia. The related compounds oxcarbazepine and eslicarbazepine are licensed for the treatment of epilepsy. These drugs can cause immune‐mediated hypersensitivity reactions, which typically affect the skin, and can be of variable severity ...
Lucy Galloway +24 more
wiley +1 more source
Aim The number of pregnancies among women with cystic fibrosis (wwCF) has steadily increased over the past decade. However, the pharmacokinetics (PK) of elexacaftor–tezacaftor–ivacaftor (ETI) during gestation remains uncharacterized, despite its widespread use in this population.
Paulette Magnas +16 more
wiley +1 more source
Time-homogeneous Markov process for HIV/AIDS progression under a combination treatment therapy: cohort study, South Africa. [PDF]
Shoko C, Chikobvu D.
europepmc +1 more source

